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Abstract. We have previously reported that chronic, recurrent 
and low-dose exposure to asbestos fibers causes a reduction in 
antitumor immunity. Investigation of natural killer (NK) cells 
using an in vitro cell line model and comprising in vitro activa-
tion using freshly isolated NK cells co-cultured with chrysotile 
fibers, as well as NK cells derived from asbestos-exposed 
patients with pleural plaque (PP) or malignant mesothelioma 
(MM), revealed decreased expression of NK cell activating 
receptors such as NKG2D, 2B4 and NKp46. An in vitro 
differentiation and clonal expansion model for CD8+ cytotoxic 
T lymphocytes (CTLs) showed reduced cytotoxicity with 
decreased levels of cytotoxic molecules such as granzyme B 
and perforin, as well as suppressed proliferation of CTLs. 
Additionally, analysis of T helper cells showed that surface 
CXCR3, chemokine receptor, and the productive potential of 
interferon (IFN)γ were reduced following asbestos exposure 
in an in vitro cell line model and in peripheral CD4+ cells of 
asbestos-exposed patients. Moreover, experiments revealed 
that asbestos exposure enhanced regulatory T cell (Treg) func-
tion. This study also focused on CXCR3 expression and the 
Th-17 cell fraction. Following activation with T-cell receptor 
and co-culture with various concentrations of chrysotile fibers 
using freshly isolated CD4+ surface CXCR3 positive and nega-
tive fractions, the intracellular expression of CXCR3, IFNγ and 
IL-17 remained unchanged when co-cultured with chrysotile. 
However, subsequent re-stimulation with phorbol 12-myristate 
13-acetate (PMA) and ionomycin resulted in enhanced IL-17 
production and expression, particularly in CD4+ surface 
CXCR3 positive cells. These results indicated that the balance 
and polarization between Treg and Th-17 fractions play an 
important role with respect to the immunological effects of 
asbestos and the associated reduction in antitumor immunity.
Introduction
Asbestos and silica are the most well-known causative, 
environmental and occupational substances that induce pneu-
moconiosis (1-3). The initial event following entry of these 
substances into the human body involves the action of immune 
competent cells such as alveolar macrophages to treat these 
foreign materials by activating the NOD-like receptor family, 
pyrin domain containing 3 (NLRP3: NALP3) inflammasome 
to produce interleukin (IL)-1β and attract fibroblasts (4-6).
Since the immunological effects of asbestos fibers have 
not been thoroughly investigated, we decided to study the 
various effects of asbestos on human immune competent cells. 
Investigation of natural killer (NK) cells using in vitro chronic 
exposure in an NK cell line and freshly isolated NK cells 
derived from healthy volunteers (HV) showed a reduction in 
NK cell activating receptors such as NKG2D and 2B4, as well 
as intracellular granzyme A, and decreased phosphorylation 
of ERK (7,8). In addition to these findings, studies of periph-
eral blood NK cells from asbestos-exposed patients with 
pleural plaque (PP) or malignant mesothelioma (MM) showed 
decreased expression of NKp46 activating receptor (7-9). 
Furthermore, the differentiation and proliferation of CD8+ 
cytotoxic T lymphocytes (CTLs) were also impaired by 
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asbestos exposure. The cytotoxicity for allogeneic targets 
decreased in peripheral blood mononuclear cells (PBMCs) 
exposed to chrysotile B (CB) asbestos, but not in cells 
exposed to crocidolite (CR) asbestos, when compared with 
PBMCs without exposure during a mixed lymphocyte reac-
tion (MLR) (10). Exposure to CB during the MLR resulted 
in suppression of an increase in granzyme B+ cells and 
interferon (IFN)γ positive cells. CB exposure also resulted 
in suppression of increases in CD45RO+ effector/memory 
cells and CD25+-activated cells in CD8+ lymphocytes, and 
a decrease in CD45RA+ cells. Furthermore, CB exposure 
suppressed the proliferation of CD8+ lymphocytes without 
yielding an increase in Annexin V+ apoptotic cells in CD8+ 
lymphocytes. Moreover, the production of IL-10, IFNγ and 
tumor necrosis factor (TNF)-α, but not IL-2, decreased in the 
presence of CB (10-13).
Our research also established a model involving chronic 
and continuous exposure to asbestos for the investigation 
of CD4+ T helper (Th) cells. Transient and relatively high-
dose exposure to asbestos caused apoptosis in a human 
T-cell leukemia virus type (HTLV)-1 immortalized human 
polyclonal T-cell line, MT-2, by the production of reactive 
oxygen spices (ROS). Activation of the pro-apoptotic MAK 
transduction signaling pathway such as p38 and JUN, and 
activation of the mitochondrial apoptotic pathway during 
continuous and relatively low-dose (in which the occurrence 
of apoptosis was <50%) exposure for more than one year 
resulted in MT-2 being more resistant to asbestos-induced 
apoptosis (14). Several independent sublines of MT-2 continu-
ously exposed to asbestos showed upregulation of IL-10 and 
transforming growth factor (TGF)β, and activation of signal 
transducer and activator of transcription 3 (STAT3) and 
Bcl-2 (15). Additionally, these sublines showed alterations in 
cytoskeletal molecules such as β-actin and vimentin (16). The 
results obtained from these sublines continuously exposed to 
asbestos revealed reduced expression of C-X-C chemokine 
receptor type 3 (CXCR3) and a decreased potential for IFNγ 
production. These results were also observed in CD4+ cells 
derived from patients with PP or MM (17,18).
The overall findings concerning the immunological effects 
of asbestos on human immune competent cells indicated that 
chronic exposure to asbestos causes a reduction in antitumor 
immunity (19-21). This suggests that asbestos-exposed indi-
viduals possess gradually reduced antitumor immunity and 
subsequent increased susceptibility to the onset of cancer. 
This may explain the long latency period observed in asbestos-
exposed individuals before they develop malignant tumors 
following initial exposure to asbestos, and this sensitivity may 
lead to the development of lung cancer and MM, in addition to 
other malignancies such as those of the larynx, gastrointestinal 
tract and bladder (22,23).
The role of Th17 cells in the development of tumors has 
been investigated from various viewpoints, and consideration 
of the part played by Th17 cells in carcinogenesis has spawned 
various paradigms (24-27). It appears that Th17 cells play a 
complex and controversial role in tumor immunity. A study of 
the effects of asbestos on Th17 cells in a murine model using 
erionite, which has similar chemical and physical properties 
to asbestos, demonstrated induced production of IL-17 (28). 
Similarly, a study utilizing amphibole asbestos, but not 
chrysotile asbestos, demonstrated induced production of IL-17 
in a murine model (29). Both of these studies indicated that the 
recorded upregulation of IL-17 was related to the production 
of autoantibodies and assumed that autoimmune disease might 
be caused by asbestos exposure (29-31). However, the precise 
manner by which asbestos exposure affects IL-17 production 
and alters Th cell-type commensuration is unclear. At the very 
least, we found that exposure of T cells to asbestos causes a 
reduction in CXCR3 and IFNγ under the experimental condi-
tions employed and in asbestos-exposed patients with PP or 
MM (17,18). These findings were thought to be very important 
in assessing antitumor immunity in Th cells since CXCR3- 
expressing Th cells recruit IFNγ-producing antitumor Th 
into the area surrounding the tumor. However, the activity of 
both processes might be reduced in asbestos-exposed patients. 
Taken together, it might be of value to determine whether 
asbestos can induce inhibition of the cellular features of Th17 
cells. The issue therefore is to determine the manner by which 
asbestos affects Th17 cells. In an effort to address this matter, 
freshly isolated human peripheral CD4+ cells were activated 
in vitro with chrysotile asbestos, since the use of chrysotile 
in industrial and commercial products is higher than that of 
amphibole asbestos, and the immunological effects were 
found to be similar for both forms of asbestos as we previ-
ously reported (32). We then investigated IL-17 expression and 
production in relation to CXCR3 expression. Since a reduction 
in CXCR3 expression was observed following asbestos expo-
sure, the cellular roles of IL-17 production and expression in 
CXCR3 positive and negative cells were examined.
Materials and methods
Peripheral blood cell preparation and intracellular staining. 
Peripheral blood T cells were prepared from three HV. 
Peripheral blood was drawn from the vein with the aid of 
heparin. PBMCs were isolated using the Ficoll-Hypaque 
method. Cells were then stained with anti-CD4 monoclonal 
antibody (mAb) and anti-CXCR3 mAb. Both antibodies were 
purchased from BD Biosciences, Minneapolis, MN, USA. 
PBMCs stained by both antibodies were divided into two 
fractions comprising CD4+ and surface CXCR3 negative 
(CD4+sCXCR3-) or positive (CD4+sCXCR3+) cells (Fig. 1A). 
Cells in two fractions (CD4+sCXCR3-  or CD4+sCXCR3+, 
1x106 cells) were stimulated with 1 µg/ml of plate-coated 
anti-CD3 mAb and 1 µg/ml of soluble anti-CD28 mAb with 
10 µg/ml of IL-2 for four weeks (Fig. 1B). These cultures 
received 0, 10, 25 or 50 µg/ml of chrysotile asbestos.
The chrysotile asbestos was removed following cultivation 
using the Ficoll-Hypaque method and intracellular expression 
of CXCR3, IFNγ and IL-17 was analyzed using mAbs for 
these molecules (BD Biosciences). Intracellular staining was 
performed using a Cytofix/Cytoperm kit (BD Biosciences) in 
accordance with the manufacturer's instructions. Cells were 
stained with individual mAbs for 30 min and then subjected to 
FACSCalibur flow cytometry.
Additionally, cells cultured with various concentrations 
of chrysotile were re-activated using phorbol 12-myristate 
13-acetate (PMA) and ionomycin (IM) for 4 h. Human 
PBMCs were obtained for this study from H.V. who provided 
written informed consent according to guidelines established 
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by the ethics committee of the Kawasaki Medical School, 
Kurashiki, Japan.
CBA assay of culture supernatants. As shown in Fig. 1B, 
activated cells from two fractions (CD4+sCXCR3-  and 
CD4+sCXCR3+) co-cultured for four weeks with various 
concentrations of chrysotile were re-stimulated by PMA and 
ionomycin for 4 h. These supernatants were subjected to CBA 
assays (BD Biosciences) to measure the concentration of 
IL-17 and IFNγ.
Real-time RT-PCR. Total RNA was extracted from cells 
re-stimulated by PMA and ionomycin and derived from two 
fractions (CD4+sCXCR3+ and CD4+sCXCR3-) activated for 
four weeks and co-cultured with various concentrations of 
chrysotile using RNAzol. Following synthesis of the first 
strand of cDNA, real-time RT-PCR was performed using the 
SYBER Green method (Takara, Shiga, Japan) with the 
Mx3000P QPCR System (Agilent Technologies, Inc., Santa 
Clara, CA), as previously described (Maeda et al, 16-18,32). 
The following primers were used; for CXCR3: forward (F), 
5'-ACACCTTCCTGCTCCACCTA-3',  reverse  (R), 
5'- GTTCAGGTAGCGGTCAAAGC-3');  for  IL-17: 
F,  5'-ACCAATCCCAAAAGGTCCTC-3', R, 5'-CCCACGGA 
CACCAGTATCTT-3'; for T-bet: F, 5'-AGGTGTCGGGG 
AAACTGAG-3', R, 5'-ACCACGTCCACAAACATCCT-3'; 
and for RORγt: F, 5'-AAATCTGTGGGGACAAGTGG-3', 
R, 5'-TCCCTCTGCTTCTTGGACAT-3'.
Statistical analysis. Statistical analyses were performed 
using SPSS version 21 (IBM Japan, Tokyo, Japan). Group 
comparisons in this study were performed as follows. The 
first comprised a comparison of intracellular CXCR3, IFNγ 
or IL-17 expression in CD4+CXCR3+ or CD4+CXCR3- frac-
tions derived from cells cultured in the absence or presence of 
various concentrations of chrysotile fibers. The next involved 
a comparison of IFNγ and IL-17 levels in supernatants of 
CD4+CXCR3+ or CD4+CXCR3- fractions from cells cultured 
in the absence or presence of various concentrations of chryso-
tile fibers. Additionally, real-time RT-PCR was employed to 
examine mRNA expression levels of T-bet, IFNγ, RORγT or 
IL-17 of CD4+CXCR3+ or CD4+CXCR3- fractions from cells 
cultured in the absence or presence of various concentrations 
of chrysotile fibers. All statistical analyses were subjected to 
the one-way ANOVA test and subsequent post-hoc compari-
sons were made using the Mann-Whitney U test.
Figure 1. (A) Representative flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) (area P1). Cells were stained with anti-CD4 and anti-
CXCR3 monoclonal antibodies, and CD4+ and surface CXCR3 negative (sCXCR3-) (area P3) or positive (sCXCR3+) (area P2) fractions were sorted by flow 
cytometry and then utilized for subsequent experiments. Cells in area P2 were not used for this analysis. (B) CD4+sCXCR3- and CD4+sCXCR3+ fractions 
were activated by anti-CD3 and anti-CD28 monoclonal antibodies with IL-2. In addition to this activation, cells were co-cultured with various concentrations 
of chrysotile asbestos fibers (0, 10, 25 or 50 µg/ml). These concentrations were compatible with our previous experiments which showed that transient and 
relatively high doses of chrysotile caused apoptosis in the human T-cell line. Following four weeks of cultivation and subsequent removal of chrysotile fibers, 
the intracellular expression of CXCR3, IFNγ and IL-17 was examined in cells from both fractions by flow cytometry. Additionally, cells from both fractions 
following activation and co-cultivation with chrysotile were stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin (IM) for 4 h. Culture 
supernatants were then used for the measurement of IFNγ and IL-17. Cells were also analyzed for T-bet, IFNγ, RORγt and IL-17 mRNA expression.
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Results
Intracellular CXCR3 expression following cultivation with 
chrysotile. CD4+sCXCR3- and CD4+sCXCR3+ cells were 
cultured in the presence of various concentrations of chryso-
tile (0, 10, 25 or 50 µg/ml) for four weeks with T-cell receptor 
(TCR) stimulation and IL-2. Following this activation period, 
intracellular CXCR3 expression was analyzed by flow cyto-
metry (Fig. 2). The intracellular expression of CXCR3 was 
significantly higher in CD4+sCXCR3+ cells compared with 
CD4+sCXCR3- cells in both R1 (totally positive cell fraction) 
and R2 (highly positive fraction) regions. The results showed 
that although intracellular CXCR3 expression remained 
unaltered in cells derived from CD4+sCXCR3+ fractions, the 
presence of chrysotile tended to reduce the highly positive 
intracellular expression of CXCR3 in cells that were initially 
CD4+sCXCR3-.
Intracellular IFNγ expression following cultivation with 
chrysotile. Levels of IFNγ were examined in CD4+sCXCR3- 
and CD4+sCXCR3+ fractions derived from cells cultured with 
various concentrations of chrysotile (Fig. 3). The intracellular 
expression of IFNγ was significantly higher in CD4+sCXCR3+ 
cells compared with CD4+sCXCR3- cells in both R1 (totally 
positive cell fraction) and R2 (highly positive fraction) regions. 
The results revealed that the initial CD4+sCXCR3- cells 
tended to display reduced IFNγ expression when cells were 
co-cultured with relatively low doses of chrysotile, although 
exposure to chrysotile did not alter intracellular IFNγ expres-
sion in any of the three fractions.
Intracellular IL-17 expression following cultivation with 
chrysotile. Intracellular IL-17 expression was analyzed in 
CD4+sCXCR3- and CD4+sCXCR3+ fractions derived from 
cells following activation and cultivation with various concen-
trations of chrysotile (Fig. 4). The intracellular expression 
of IL-17 was significantly higher in CD4+sCXCR3+ cells 
compared with CD4+sCXCR3- cells in both R1 (totally posi-
tive cell fraction) and R2 (highly positive fraction) regions. 
The results showed that CD4+ fractions tended to display 
increased intracellular IL-17 expression, although there were 
no significant differences in intracellular IL-17 expression in 
any of the fractions.
IFNγ and IL-17 production following stimulation of cells 
cultured with chrysotile. Since analysis of the intracellular 
expression of IFNγ and IL-17 in cell fractions initially divided 
as CD4+sCXCR3- and CD4+sCXCR3+ following four weeks of 
cultivation with chrysotile asbestos did not show any marked 
alterations, these cells were re-stimulated by PMA and iono-
mycin for 4 h as shown in Fig. 1B. The concentration of IFNγ 
and IL-17 in culture supernatants was then measured.
As shown in Fig. 5, high levels of both IFNγ and IL-17 
were found in CD4+sCXCR3+ fractions. In contrast, IFNγ 
production remained unaltered in cells cultured with chryso-
tile (Fig. 5A). However, IL-17 production was enhanced in cells 
Figure 2. Cells from CD4+sCXCR3- and CD4+sCXCR3+ fractions following activation and co-culture with chrysotile were analyzed for intracellular expres-
sion of CXCR3. Region 1 (R1) shows the total intracellular expression and region 2 (R2) indicates a highly positive fraction. (A) Actual intracellular CXCR3 
staining results of both CD4+sCXCR3 negative or positive fractions cultured in the absence or presence of chrysotile; (B) shows changes in the percentage 
of intracellular CXCR3 positive cells. In both R1 and R2 regions, intracellular CXCR3 positive cells were higher in the CD4+sCXCR3 positive fraction 
compared with the CD4+sCXCR3 negative fraction, whereas there was no statistically significant difference between cells cultured in the absence or presence 
of chrysotile (three different concentrations). *Significant differences of <0.05. ‘n.s.’ Statistically not significant.
INTERNATIONAL JOURNAL OF ONCOLOGY  50:  2024-2032,  20172028
Figure 3. Cells from CD4+sCXCR3- and CD4+sCXCR3+ fractions following activation and co-culture with chrysotile were analyzed for intracellular expres-
sion of IFNγ. Region 1 (R1) shows the total intracellular expression and region 2 (R2) indicates a highly positive fraction. (A) Actual intracellular IFNγ staining 
results of both CD4+sCXCR3 negative or positive fractions cultured in the absence or presence of chrysotile; (B) shows changes in the percentage of intracel-
lular IFNγ positive cells. In both R1 and R2 regions, intracellular CXCR3 positive cells were higher in the CD4+sCXCR3 positive fraction compared with the 
CD4+sCXCR3 negative fraction, whereas there was no statistically significant difference between cells cultured in the absence or presence of chrysotile (three 
different concentrations). *Significant differences of <0.05. ‘n.s.’ Statistically not significant.
Figure 4. Cells from CD4+sCXCR3- and CD4+sCXCR3+ fractions following activation and co-culture with chrysotile were analyzed for intracellular expres-
sion of IL-17. Region 1 (R1) shows total intracellular expression and region 2 (R2) indicates a highly positive fraction. (A) Actual intracellular IL-17 staining 
results of both CD4+sCXCR3 negative or positive fractions cultured in the absence or presence of chrysotile; (B) Changes in the percentage of intracellular 
IL-17 positive cells. In both R1 and R2 regions, intracellular CXCR3 positive cells were higher in the CD4+sCXCR3 positive fraction compared with the 
CD4+sCXCR3 negative fraction, whereas there was no statistically significant difference between cells cultured in the absence or presence of chrysotile (three 
different concentrations). *Significant differences of <0.05. ‘n.s.’ Statistically not significant.
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cultured with chrysotile in a dose-dependent manner (Fig. 5B), 
although large variations were found.
IFNγ, T-bet, RORγT and IL-17 mRNA expression. Although 
IFNγ production remained unaltered in CD4+sCXCR3- and 
CD4+sCXCR3+ cells cultured with various concentrations 
of chrysotile asbestos, the production of IL-17 increased as 
shown in Fig. 6. Consequently, the expression of IFNγ, T-bet, 
RORγT and IL-17 mRNA was analyzed.
The results showed that cultivation with chrysotile did not 
modify the expression of T-bet, whereas IFNγ expression was 
reduced in cells initially categorized as CD4+sCXCR3-. These 
results indicated that although cultivation with chrysotile 
did not appear to alter the Th1 population, Th1 function was 
reduced and depended in particular on the initial expression 
of CXCR3.
The Th17 status in these three fractions derived from 
cells treated with PMA and ionomycin and followed by T-cell 
receptor stimulation with IL-2 and cultivation with various 
concentrations of chrysotile asbestos was then examined. IL-17 
mRNA expression was enhanced in both CD4+sCXCR3- and 
CD4+sCXCR3+ fractions, although the expression of RORγT 
increased slightly in cells co-cultured with chrysotile.
Discussion
The causative mechanisms of asbestos-induced cancer are 
thought to include 1) DNA damage due to ROS production 
by iron found in asbestos fibers, 2) direct chromosomal/
DNA damage by physical attack of cells near the inhaled 
asbestos fibers, and 3) adsorption of various carcinogenic 
substances around the fiber itself (33-36). The effect of 
these processes results in the generation of mesothelioma 
cells containing various genetic changes such as deletion of 
p16/p15 cyclin-dependent kinase-inhibitors (CDK-Is), dele-
tion of NF2/merlin, and alteration (deletions and mutations) 
of BRCA1-associated protein 1/ubiquitin carboxyl-terminal 
hydrolase (BAP1) (37-39). Mesothelioma is thought to 
result after a 30 to 40-year latency period following initial 
exposure to asbestos. During these long latency periods, and 
under conditions leading to the occurrence of other malig-
nancies such as cancers of the larynx, gastrointestinal tract 
and bladder (22,23), it is thought that individuals exposed to 
asbestos and possessing asbestos fibers in their body might 
have reduced antitumor immunity due to asbestos exposure 
and recurrent and chronic encounters between intra-body 
fibers and immune competent cells. It is on this basis that we 
have been investigating the immunological effects of asbestos 
on immune competent cells, particularly in regard to anti-
tumor immunity (19-21,40).
Investigation of Th cells showed a reduction in 
CXCR3 surface expression and impaired IFNγ production 
capacity (17,18). The T-cell line model utilized in vitro stimu-
lated freshly isolated human peripheral CD4+ cells and CD4+ 
cells derived from PP and MM (17,18). Since CXCR3 is thought 
to operate with IFNγ producing cells and functions to attack 
tumor cells, these findings also suggest that individuals exposed 
to asbestos possess reduced antitumor immunity (40).
We then investigated Th17 cells since they were considered 
to be important in the development of dysregulation of autoim-
munity and cancer (24-27). Some human cancers have been 
shown to possess increased levels of Th17 cells in the tumor, 
such as melanoma, ovarian and prostate cancers (24-27). 
Furthermore, the polarization of Th17 cells was considered 
Figure 5. As shown in Fig. 1B, cells from both fractions (CD4+sCXCR3- and CD4+sCXCR3+) following activation and co-culture with chrysotile fibers were 
re-stimulated with PMA and IM for 4 h. The concentration of IFNγ (A) and IL-17 (B) was examined in supernatants of the re-stimulated cultures. Both 
cytokines were produced mainly in CD4+sCXCR3+ fractions, rather than in CD4+sCXCR3- cells. There were statistically significant differences between 
supernatants from CD4+sCXCR3 negative and positive cells with respect to the production of IFNγ or IL-17. Although alterations in IFNγ production were 
not observed when cells were co-cultured with chrysotile, IL-17 production tended to increase when chrysotile fibers were added. Statistically significant 
differences in IL-17 production in CD4+sCXCR3 negative or positive fractions cultured in the absence or presence of chrysotile (three different concentrations) 
were not found due to the relatively large error bars. *Significant differences of <0.05. ‘n.s.’ Statistically not significant.
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to be opposite to that of CD4+CD25+ and Forkhead box 
protein P3 (FoxP3) positive regulatory T cells (Treg) (41,42). 
Since enhancement of the volume or function of Treg may 
cause a reduction in antitumor immunity that inhibits tumor-
recognizing T cells, the peripheral balance and polarizing 
conditions defined by cytokine conditions among IL-6 and 
TGFβ and between Treg and Th17 (24-27) may be altered, 
and an increase in one population may cause a decrease in 
the other population. Therefore, an increase in number of cells 
or enhancement of Th17 function may reflect augmentation of 
antitumor immunity (24-27). 
A consideration of the overall results and our previous data 
suggests that asbestos exposure reduces CXCR3 expression 
and decreases IFNγ production capacity in Th1 cells, and 
increases IL-17 production capacity in CD4+ and surface 
CXCR3+ fractions. This production capacity appears to be 
strongly related to the CXCR3 positive cell fraction (Fig. 5), 
and reduction in the surface CXCR3 positive fraction 
during asbestos exposure was associated with a reduction in 
IL-17 production capacity in peripheral blood derived from 
asbestos-exposed patients. These findings also indicated that 
the immunological effects of asbestos lead to a reduction in 
antitumor immunity, and that these mechanisms may play a 
role in the subsequent occurrence of mesothelioma and other 
cancers in asbestos-exposed individuals.
The status of Treg in asbestos-exposed patients and the 
effect of asbestos on Treg require investigation. Recently, 
we indicated that asbestos enhances Treg function through 
a cell-cell contact pathway, and increases production of 
typical soluble factors such as IL-10 and TGFβ. These inves-
tigations also showed a reduction in antitumor immunity 
in asbestos-exposed patients. However, it remains unclear 
whether chronic, recurrent and continuous exposure of T cells 
to asbestos influences the polarization of Th subpopulations 
such as Th1, Treg and Th17.
Additionally, studies of Treg and Th17 should determine 
whether there is an increase in the number and function of 
tumors surrounding these subpopulations. However, such inves-
tigations must collect all of the immune competent cells from 
rejected tumor specimens. These issues need to be examined 
in future studies in an effort to address unresolved questions 
such as the alteration of antitumor immunity in mesothelioma 
patients. However, our focus is to consider the gradual decrease 
in antitumor immunity in asbestos-exposed patients following 
initial exposure to asbestos. Therefore, it would be better to 
analyze a population that has a significant exposure history 
to asbestos, but which does not show any significant physical 
alterations or the presence of certain cancers or PP.
The overall results suggest that Treg and Th17 conditions 
should be analyzed with respect to antitumor immunity not 
only in PP and MM patients, but also in individuals who have 
a significant history of asbestos exposure without any changes 
in health and body-related issues.
An experimental model should be explored in order to 
confirm the reduction in antitumor immunity. For example, 
as previously reported, continuous exposure of the human 
NK cell line YT-A1 to chrysotile asbestos for more than five 
months resulted in reduced antitumor killing activity against 
the human erythroblastic leukemia cell line K562, a commonly 
used target cell line to assay NK cell activity and compared with 
the original YT-A1 cell line, which has never been exposed to 
asbestos fibers (7-9). Regarding our previous reports showing 
Figure 6. As shown in Fig. 1B, cells from both fractions (CD4+sCXCR3- and CD4+sCXCR3+) following activation and co-culture with chrysotile fibers were 
re-stimulated with PMA and IM for 4 h. Cells were collected and the expression of T-bet, IFNγ, RORγT and IL-17 mRNA was examined using real-time 
RT-PCR. T-bet and RORγT mRNA expression in both CD4+sCXCR3- and CD4+sCXCR3+ remained unchanged following the addition of chrysotile fibers. 
The expression of IFNγ mRNA in the CD4+sCXCR3- fraction was reduced when chrysotile fibers were added in the culture, although this reduction was not 
observed in the CD4+sCXCR3+ fraction. In contrast, the expression of IL-17 mRNA was enhanced in both CD4+sCXCR3- and CD4+sCXCR3+ cells when 
cultured with chrysotile fibers, although the expression level in CD4+sCXCR3+ cells was one-order higher than that in CD4+sCXCR3- cells for both genes. 
*Significant differences of <0.05.
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that asbestos fibers enhance Treg function (43) and increase its 
volume by acceleration of the cell cycle (44), the construction 
of a cell co-culture model using human cell lines such as a 
Treg cell model or responder T cell model with mesothelioma 
(or other cancer) model might be difficult. As we previously 
reported, subjecting a human Treg model comprising the 
MT-2 cell line to continuous exposure to asbestos resulted in 
increased production of IL-10 and TGFβ (43). The effects of 
soluble factors such as these cytokines can be assayed using a 
transwell culture model. However, these soluble factors act to 
reduce antitumor immunity by inhibiting the attack of tumor 
cells by T cells. Thus, the model should comprise two cell types 
such as tumor cells and tumor-attacking responder T cells. Of 
course, it would be possible to match the HLA of some mesothe-
lioma cell line with HV who could be used to provide PBMCs, 
including tumor attacking T cells. Thereafter, PBMCs derived 
from HLA-matched HV can be activated in vitro in the absence 
or presence of asbestos fibers. The tumor killing activity may 
then be examined in vitro with or without cell culture super-
natants derived from a human Treg cell line model cultured in 
the absence or continuous presence of asbestos fibers. Animal 
models transplanting human mesothelioma cells can also be 
employed with the induction of immune cells in the absence or 
continuous presence of asbestos. Furthermore, since antibodies 
are produced against tumor cells, human myeloma cell lines 
can be employed and we have successfully established many of 
these cell lines (45-47). These experiments should be performed 
in an effort to confirm our hypothesis that asbestos exposure 
causes a reduction in antitumor immunity.
In conclusion, we found that in vitro asbestos exposure 
of freshly isolated human T-cells induces IL-17 production. 
Further investigations regarding Th17 status in asbestos-
exposed patients with PP or MM, and in individuals who do 
not exhibit any abnormalities, should be conducted to confirm 
the status of antitumor immunity in these asbestos-exposed 
individuals. Following confirmation of these hypotheses, 
certain kinds of food compositions or physiologically active 
substances derived from plants or other materials should 
be tested for their ability to neutralize the altered antitumor 
immunity in individuals exposed to asbestos in an effort to 
thwart the development of tumors.
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